- A preview of this full-text is provided by Springer Nature.
- Learn more
Preview content only
Content available from Nature Methods
This content is subject to copyright. Terms and conditions apply.
Articles
https://doi.org/10.1038/s41592-020-0792-1
1Institute for Tissue Engineering and Regenerative Medicine (iTERM), Helmholtz Zentrum München, Neuherberg, Germany. 2Institute for Stroke and
Dementia Research (ISD), Ludwig-Maximilians-Universität (LMU), Munich, Germany. 3Graduate School of Neuroscience (GSN), Munich, Germany.
4Department of Computer Science, Technical University of Munich (TUM), Munich, Germany. 5Center for Translational Cancer Research of the TUM
(TranslaTUM), Munich, Germany. 6Munich School of Bioengineering, Technical University of Munich (TUM), Munich, Germany. 7Institute of Pharmacology
and Toxicology, University of Zurich (UZH), Zurich, Switzerland. 8Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. 9German Center
for Neurodegenerative Diseases (DZNE), Munich, Germany. 10These authors contributed equally: Mihail Ivilinov Todorov, Johannes Christian Paetzold.
11These authors jointly supervised this work: Bjoern Menze, Ali Ertürk. ✉e-mail: bjoern.menze@tum.de; erturk@helmholtz-muenchen.de
Changes in cerebrovascular structures are key indicators for a
large number of diseases affecting the brain. Primary angiop-
athies, vascular risk factors (for example, diabetes), traumatic
brain injury, vascular occlusion and stroke all affect the function of
the brain’s vascular network1–3. The hallmarks of Alzheimer’s dis-
ease, including tauopathy and amyloidopathy, can also lead to aber-
rant remodeling of blood vessels1,4, allowing capillary rarefaction to
be used as a marker for vascular damages5. Therefore, quantitative
analysis of the entire brain vasculature is pivotal to developing a
better understanding of brain function in physiological and patho-
logical states. However, quantifying micrometer-scale changes in
the cerebrovascular network of the brain has been difficult for two
main reasons.
First, labeling and imaging of the complete mouse brain vascu-
lature down to the smallest blood vessels has not yet been achieved.
Magnetic resonance imaging (MRI), micro-computed tomography
(micro-CT) and optical coherence tomography do not have suffi-
cient resolution to capture capillaries in bulk tissue6–8. Fluorescent
microscopy provides higher resolution, but can typically only
be applied to tissue sections up to 200 μm in thickness9. Recent
advances in tissue clearing could overcome this problem10, but so
far there has been no systematic description of all vessels of all sizes
in an entire brain in three dimensions (3D).
The second challenge relates to the automated analysis of large
3D imaging datasets with substantial variance in signal intensity
and signal-to-noise ratio (SNR) at different depths. Simple inten-
sity- and shape-based filtering approaches such as Frangi’s vessel-
ness filters and more advanced image processing methods with
local spatial adaptation cannot reliably differentiate vessels from
background in whole-brain scans11,12. Finally, imaging of the com-
plete vascular network of the brain at capillary resolution results
in datasets of terabyte size. Established image processing methods
do not scale well to terabyte-sized image volumes, as they do
not generalize well to large images, and require intensive manual
fine-tuning13–15.
Here we present VesSAP (Vessel Segmentation & Analysis
Pipeline), a deep learning-based method for automated analysis of
the entire mouse brain vasculature, overcoming the above limita-
tions. VesSAP encompasses three major steps: (1) staining, clearing
and imaging of the mouse brain vasculature down to the capil-
lary level with two different dyes: wheat germ agglutinin (WGA)
and Evans blue (EB); (2) automatic segmentation and tracing of
the whole-brain vasculature data via CNNs; and (3) extraction of
vascular features for hundreds of brain regions after registration of
the data to the Allen brain atlas (Fig. 1). Our deep learning-based
approach for network extraction in cleared tissue is robust, despite
variations in signal intensities and structures, outperforms previ-
ous filter-based methods and reaches the quality of segmentation
achieved by human annotators. We applied VesSAP to the three
commonly used mouse strains C57BL/6J, CD1 and BALB/c.
Results
Vascular staining, DISCO clearing and imaging. To reliably stain
the entire vasculature, we used WGA and EB dyes, which can be
visualized in different fluorescence channels. We injected EB dye
into live mice 12 h before WGA perfusion, allowing its long-term
circulation to mark vessels under physiological conditions16, while
we perfused mice with WGA during fixation. We then performed
Machine learning analysis of whole mouse brain
vasculature
Mihail Ivilinov Todorov1,2,3,10, Johannes Christian Paetzold4,5,6,10, Oliver Schoppe4,5, Giles Tetteh4,
Suprosanna Shit4,5,6, Velizar Efremov4,7, Katalin Todorov-Völgyi2, Marco Düring2,8, Martin Dichgans2,8,9,
Marie Piraud4, Bjoern Menze 4,5,6,11 ✉ and Ali Ertürk 1,2,8,11 ✉
Tissue clearing methods enable the imaging of biological specimens without sectioning. However, reliable and scalable analysis
of large imaging datasets in three dimensions remains a challenge. Here we developed a deep learning-based framework to
quantify and analyze brain vasculature, named Vessel Segmentation & Analysis Pipeline (VesSAP). Our pipeline uses a con-
volutional neural network (CNN) with a transfer learning approach for segmentation and achieves human-level accuracy. By
using VesSAP, we analyzed the vascular features of whole C57BL/6J, CD1 and BALB/c mouse brains at the micrometer scale
after registering them to the Allen mouse brain atlas. We report evidence of secondary intracranial collateral vascularization
in CD1 mice and find reduced vascularization of the brainstem in comparison to the cerebrum. Thus, VesSAP enables unbiased
and scalable quantifications of the angioarchitecture of cleared mouse brains and yields biological insights into the vascular
function of the brain.
NATURE METHODS | VOL 17 | APRIL 2020 | 442–449 | www.nature.com/naturemethods
442
Content courtesy of Springer Nature, terms of use apply. Rights reserved